What is ipilimumab (Yervoy), and how is it used?
Yervoy is a prescription medicine used:
- to treat a kind of skin cancer called melanoma. Yervoy may be used:
- in people with kidney cancer (renal cell carcinoma). Yervoy may be used in combination with nivolumab in certain people when their cancer has spread.
- in adults and children 12 years of age and older, with a type of colon or rectal cancer (colorectal cancer). Yervoy in combination with nivolumab may be used when your colon or rectal cancer:
- has spread to other parts of the body (metastatic).
- is microsatellite stability-high (MSI-H) or mismatch repair deficient (dMMR), and
- You have tried treatment with a fluoropyrimidine, oxaliplatin, and irinotecan, and it did not work or is no longer working.
It is not known if Yervoy is safe and effective in children younger than 12 years of age.
What are the side effects of ipilimumab (Yervoy)?
Yervoy can cause serious side effects in many parts of your body which can lead to death. These problems may happen anytime during treatment with Yervoy or after you have completed treatment. Some of these problems may happen more often when Yervoy is used in combination with nivolumab. Call your healthcare provider right away if you develop any of these signs or symptoms or they get worse. Do not try to treat symptoms yourself.
Intestinal problems (colitis) that can cause tears or holes (perforation) in the intestines
Signs and symptoms of colitis may include:
- diarrhea (loose stools) or more bowel movements than usual
- mucus or blood in your stools
- dark, tarry, sticky stools
- stomach pain (abdominal pain) or tenderness
- you may or may not have fever
Liver problems (hepatitis) that can lead to liver failure
Signs and symptoms of hepatitis may include:
- yellowing of your skin or the whites of your eyes
- dark urine (tea colored)
- nausea or vomiting
- pain on the right side of your stomach
- bleeding or bruise more easily than normal
- decreased energy
Skin problems that can lead to severe skin reaction
Signs and symptoms of severe skin reactions may include:
Nerve problems that can lead to paralysis
Symptoms of nerve problems may include:
Hormone gland problems (especially the pituitary, adrenal, and thyroid glands)
Signs and symptoms that your glands are not working properly may include:
- persistent or unusual headaches
- unusual sluggishness
- feeling cold all the time
- weight gain
- changes in mood or behavior such as decreased sex drive, irritability, or forgetfulness
- dizziness or fainting Lung problems (pneumonitis).
Symptoms of pneumonitis may include:
- new or worsening cough
- chest pain
- shortness of breath Kidney problems, including nephritis and kidney failure.
Signs of kidney problems may include:
- decrease in the amount of urine
- blood in your urine
- swelling in your ankles
- loss of appetite Inflammation of the brain (encephalitis).
Signs and symptoms of encephalitis may include:
- tiredness or weakness
- memory problems
- seeing or hearing things that are not really there (hallucinations)
- stiff neck
Symptoms may include:
Severe infusion reactions
Tell your doctor or nurse right away if you get these symptoms during an infusion of Yervoy:
Common side effects
The most common side effects of Yervoy when used alone include:
- feeling tired
- weight loss
- decreased appetite
- difficulty falling or staying asleep
The most common side effects of Yervoy when used in combination with nivolumab include:
- feeling tired
- pain in muscles, bones, and joints
- abdominal pain
- decreased appetite
- shortness of breath
These are not all of the possible side effects of Yervoy. Call your doctor for medical advice about side effects.
What is the dosage of ipilimumab (Yervoy)?
Yervoy alone is given to you into your vein through an intravenous (IV) line over 90 minutes.
- When Yervoy is used in combination with nivolumab, nivolumab is given to you into your vein through an IV line over 30 minutes. Then Yervoy is also given through an IV over 30 minutes on the same day.
- Yervoy in combination with nivolumab is usually given every 3 weeks for 4 doses. After that, nivolumab alone is usually given every 2 or 4 weeks.
- Your healthcare provider will decide how many treatments you will need.
- Your healthcare provider will do blood tests before starting and during treatment with Yervoy.
- It is important for you to keep all appointments with your healthcare provider. Call your healthcare provider if you miss an appointment. There may be special instructions for you.
Unresectable or metastatic melanoma:
Yervoy 3 mg/kg administered intravenously over 90 minutes every 3 weeks for a total of 4 doses.
Yervoy 10 mg/kg administered intravenously over 90 minutes every 3 weeks for 4 doses, followed by 10 mg/kg every 12 weeks for up to 3 years or until documented disease recurrence or unacceptable toxicity.
Advanced renal cell carcinoma:
Nivolumab 3 mg/kg administered intravenously over 30 minutes followed by Yervoy 1 mg/kg administered intravenously over 30 minutes on the same day, every 3 weeks for 4 doses, then nivolumab 240 mg every 2 weeks or 480 mg every 4 weeks, administered intravenously over 30 minutes.
Latest Medications News
Daily Health News
What drugs interact with ipilimumab (Yervoy)?
No formal pharmacokinetic drug interaction studies have been conducted with Yervoy.
Is ipilimumab (Yervoy) safe to use while pregnant or breastfeeding?
Do not breastfeed during treatment with Yervoy and for 3 months after the last dose of Yervoy.
Ipilimumab (Yervoy) is a prescription medicine used to treat melanoma skin cancer when melanoma has spread or cannot be removed by surgery and to help prevent melanoma from coming back after it and lymph nodes that contain cancer have been removed by surgery, in people with kidney cancer (renal cell carcinoma), and in adults and children 12 years of age and older with colon or rectal cancer (colorectal cancer).
Multimedia: Slideshows, Images & Quizzes
Understanding Cancer: Metastasis, Stages of Cancer, and More
Learn the basics about cancer including types, causes, how it spreads, symptoms and signs, stages and treatment options. Read...
Colorectal Cancer: Symptoms, Signs, Screening, Stages
Colorectal cancer (colon cancer) is the cause of many cancer deaths. Learn about the warning signs, symptoms, screening process,...
Colon Cancer: How Your Diet Can Affect Colorectal Cancer
Diet, including nutrient, antioxidant, and vitamin intake, affects colon cancer risk. Certain dietary factors either decrease or...
Colorectal (Colon) Cancer Quiz: Test Your Medical IQ
What is colorectal (colon) cancer and who gets it? Take this quiz to find out how this disease may be prevented.
Melanoma (Skin Cancer) Quiz: Symptoms & Signs
What causes skin cancer? Take our Skin Cancer Quiz to learn about the risks, symptoms, causes, and treatments for this common...
Picture of Lentigo Maligna Melanoma
One of the four clinical types of malignant melanoma and the slowest growing one. See a picture of Lentigo Maligna Melanoma and...
Cancer: How to Lower and Cut Your Risk of Cancer
About a third of all cases of cancer can be prevented. Find out how to lower your chances of getting it.
Picture of Colon Cancer
Most, if not all, of these cancers develop from colonic polyps. Removal of these precancerous polyps can prevent colon cancer....
Picture of Malignant Melanoma
Less than 2 percent of all melanomas occur during childhood. Nonetheless, attention must be paid to signs and symptoms suggestive...
Picture of Desmoplastic Melanoma
A flat nodule with bluish-red and brown portion in an elderly malea. See a picture of Desmoplastic Melanoma and learn more about...
Related Disease Conditions
Colon cancer (bowel cancer) is a malignancy that arises from the inner lining of the colon. Most, if not all, of these cancers develop from colonic polyps. Removal of these precancerous polyps can prevent colon cancer.
Skin cancers occur when skin cells undergo malignant transformations and grow into tumors. The most common types of skin cancer, basal cell carcinoma and squamous cell carcinoma, are highly curable when they are diagnosed and treated early. Sun exposure, tanning beds, depressed immune system, radiation exposure, and certain viral infections are risk factors for skin cancer. Skin cancers are treated with surgery or radiation. The prognosis of nonmelanoma skin cancers is generally very good.
Melanoma (Skin Cancer)
Melanoma is a type of skin cancer which begins in skin cells called melanocytes and affects more than 53,600 people in the United States each year. These melanocytes can grow together to form benign moles which, after a change in size, shape, or color can be a sign of melanoma. Caused by sun exposure, early detection becomes extremely important to avoid a spread to other areas of the body. Diagnosis is confirmed through a biopsy of the abnormal skin and treatment depends on the extent and characteristics of the patient. Metastatic melanoma is melanoma that has spread to various organs.
There are several types of kidney cancer, including renal cell cancer (renal adenocarcinoma or hypernephroma), transitional cell carcinoma, and Wilms tumor. Symptoms of kidney cancer include blood in the urine, an abdominal lump or mass, chronic pain in the side, and tiredness. Treatment of kidney cancer -- which may include surgery, arterial embolization, radiation therapy, biological therapy or chemotherapy -- depends upon the stage of the disease and the patient's overall health.
Treatment & Diagnosis
- Colon Cancer
- Doctor: Checklist to Take To Your Doctor's Appointment
- Kidney Cancer
- How to Choose a Doctor
- Doctor: Getting the Most from Your Doctor's Appointment
- Melanoma: Prevention, Detection, and Treatment
- Colorectal Cancer Issues: An Update with Doctors
- Cancer Pain Management with Ann Reiner
- Cancer Patients Need Proper Diet and Exercise
- Colon Cancer Update
- Cancer Research: Going the Distance
Medications & Supplements
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
All content is from the U.S. Food and Drug Administration (FDA) prescribing information.